Omnicare (NYSE:OCR) traded at a new 52-week high today of $43.59. Approximately 536,000 shares have changed hands today, as compared to an average 30-day volume of 1.1 million shares.
Omnicare, Inc. provides geriatric pharmaceutical services. The Company distributes pharmaceuticals, and provides related pharmacy consulting and other ancillary services, data management services and medical supplies to skilled nursing facilities, assisted living facilities, retirement centers, independent living communities, hospitals, hospice, and other healthcare providers.
Omnicare has overhead space with shares priced $43.59, or 0.0% below the average consensus analyst price target of $43.60. The stock should discover initial support at its 50-day moving average (MA) of $39.82 and subsequent support at its 200-day MA of $36.00.
Omnicare share prices have moved between a 52-week high of $43.59 and a 52-week low of $29.24 and are now trading 49% above that low price at $43.59 per share. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 0.5%.